Loading quotes...
Forecast
The analysts' average price target is €62.60 (-0.06%). The median is €64.72 (+3.32%).
| Buy |
Â
27 |
| Hold |
Â
16 |
| Sell |
Â
1 |
News Go to news feed
Centene rolls out "Gold Card" program and eliminates prior authorizations for doctors
Centene announced a "Gold Card" program that initially removes bureaucratic prior authorizations for certain outpatient treatments for more than 160,000 doctors. The initiative aims to cut internal administrative costs and strengthen ties to a high-quality physician network. The program complements Centene's strong position in government health programs and follows an upward revision of its profit outlook. » More on finanzen.net
Centene hits 52-week high of $69.36 after sharp rally
Centene shares climbed to a 52-week high of $69.36, nearly doubling over the past year; they rose 93% in the last six months and the market capitalization is $34.2 billion. Analysts raised earnings estimates and price targets (including Truist $80, Bernstein $79, Cantor Fitzgerald $75) after stronger Q2 results, an improved medical loss ratio and an upgraded 2026 outlook. Positive drivers also include stabilizing Medicaid margins, higher premiums in the Marketplace and Medicare Advantage businesses, and favorable risk selection in the Marketplace segment. » More on de.investing.com
Bradley Bolivar named chief information officer at Centene
Centene appoints Bradley Bolivar as chief information officer effective immediately. Bolivar joins from Fannie Mae and brings nearly three decades of leadership experience in technology, cybersecurity, data and AI. He succeeds Brian LeClaire, who will retire as planned at the end of October 2026, and is expected to advance Centene’s technology capabilities to improve healthcare. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 38.88bn | 5.98% |
| Gross profit | 4.05bn | 61.80% |
| Net profit | 955.95m | 545.35% |
| EBITDA | 1.7bn | 778.29% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €30.94bn |
Number of shares | 494m |
52-week high/low | €64.72 - €28.24 |
| Dividends | No |
Beta | 1.13 |
P/E ratio | -6.75 |
PEG ratio | 0.02 |
P/B ratio | 1.54 |
P/S ratio | 0.18 |
Company profile
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
| Name | Centene |
| CEO | Sarah McGinty London |
| Headquarters | St. Louis,
mo USA |
| Website | |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| IPO | 13/12/2001 |
| Employees | 61,100 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | CNC |
London Stock Exchange | 0HVB.L |
Frankfurt | QEN.F |
DĂĽsseldorf | QEN.DU |
Milan | 1CNC.MI |
London | 0HVB.L |
SIX | QEN.SW |
MĂĽnchen | QEN.MU |